Brief: Cbdmd Engages Leading Biotech Firm Iontox To Validate Its Patent Pending Superior Broad Spectrum Blend
cbdMD Inc YCBD.A :
* CBDMD ENGAGES LEADING BIOTECH FIRM IONTOX TO VALIDATE ITS
PATENT
PENDING SUPERIOR BROAD SPECTRUM BLEND
Source text for Eikon: ID:nBw4cLJHba
Further company coverage: YCBD.A
Recent news on cbdMD
See all newsBrief: CbdMD Reports 19% Year-Over-Year And 12% Sequential Revenue Growth
Brief: cbdMD Announces Strategic Acquisition of Bluebird Botanicals
Brief: Cbdmd Reports Preliminary Unaudited Fourth Quarter Results
Brief: CbdMD Inc - Effective Sep 30, Enters Securities Purchase Agreements With Four Investors - SEC Filing
Brief: CbdMD Inc - Reduces Principal On Senior Secured Convertible Notes To $56,000